For example, in patients with non-small cell lung cancer, high expression of PD-1 marked a particularly dysfunctional subset of T-cells characterised by co-expression of multiple other immune checkpoints and was associated with poor restoration of T-cell effector function following PD-1 blockade.80 This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.